Global Pharmaceutical Asset Managements Market Size, Status and Forecast 2020-2026

May 2020 | 94 pages | ID: G6F3C123E0A5EN
QYResearch

Abstracts

This report focuses on the global Pharmaceutical Asset Managements status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Asset Managements development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• McKesson Corporation
• Cerner Corporation
• Siemens Healthcare
• GE Healthcare
• Allscripts
• Epic System
• IBM Corporation
• ...

Market segment by Type, the product can be split into

• Hardware (Pharma Asset)
• Software (Pharma Asset)

Market segment by Application, split into

• Anti-drug Counterfeiting
• Supply Chain Management
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmaceutical Asset Managements status, future forecast, growth opportunity, key market and key players.
• To present the Pharmaceutical Asset Managements development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical Asset Managements are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Asset Managements Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmaceutical Asset Managements Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hardware (Pharma Asset)
  1.4.3 Software (Pharma Asset)
1.5 Market by Application
  1.5.1 Global Pharmaceutical Asset Managements Market Share by Application: 2020 VS 2026
  1.5.2 Anti-drug Counterfeiting
  1.5.3 Supply Chain Management
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmaceutical Asset Managements Market Perspective (2015-2026)
2.2 Pharmaceutical Asset Managements Growth Trends by Regions
  2.2.1 Pharmaceutical Asset Managements Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmaceutical Asset Managements Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmaceutical Asset Managements Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmaceutical Asset Managements Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmaceutical Asset Managements Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmaceutical Asset Managements Players by Market Size
  3.1.1 Global Top Pharmaceutical Asset Managements Players by Revenue (2015-2020)
  3.1.2 Global Pharmaceutical Asset Managements Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmaceutical Asset Managements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Asset Managements Market Concentration Ratio
  3.2.1 Global Pharmaceutical Asset Managements Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Asset Managements Revenue in 2019
3.3 Pharmaceutical Asset Managements Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Asset Managements Product Solution and Service
3.5 Date of Enter into Pharmaceutical Asset Managements Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmaceutical Asset Managements Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Type (2021-2026)

5 PHARMACEUTICAL ASSET MANAGEMENTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmaceutical Asset Managements Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmaceutical Asset Managements Market Size (2015-2020)
6.2 Pharmaceutical Asset Managements Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Asset Managements Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Asset Managements Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmaceutical Asset Managements Market Size (2015-2020)
7.2 Pharmaceutical Asset Managements Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Asset Managements Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Asset Managements Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmaceutical Asset Managements Market Size (2015-2020)
8.2 Pharmaceutical Asset Managements Key Players in China (2019-2020)
8.3 China Pharmaceutical Asset Managements Market Size by Type (2015-2020)
8.4 China Pharmaceutical Asset Managements Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmaceutical Asset Managements Market Size (2015-2020)
9.2 Pharmaceutical Asset Managements Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Asset Managements Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Asset Managements Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmaceutical Asset Managements Market Size (2015-2020)
10.2 Pharmaceutical Asset Managements Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Asset Managements Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Asset Managements Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmaceutical Asset Managements Market Size (2015-2020)
11.2 Pharmaceutical Asset Managements Key Players in India (2019-2020)
11.3 India Pharmaceutical Asset Managements Market Size by Type (2015-2020)
11.4 India Pharmaceutical Asset Managements Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmaceutical Asset Managements Market Size (2015-2020)
12.2 Pharmaceutical Asset Managements Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Asset Managements Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Asset Managements Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 McKesson Corporation
  13.1.1 McKesson Corporation Company Details
  13.1.2 McKesson Corporation Business Overview and Its Total Revenue
  13.1.3 McKesson Corporation Pharmaceutical Asset Managements Introduction
  13.1.4 McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020))
  13.1.5 McKesson Corporation Recent Development
13.2 Cerner Corporation
  13.2.1 Cerner Corporation Company Details
  13.2.2 Cerner Corporation Business Overview and Its Total Revenue
  13.2.3 Cerner Corporation Pharmaceutical Asset Managements Introduction
  13.2.4 Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.2.5 Cerner Corporation Recent Development
13.3 Siemens Healthcare
  13.3.1 Siemens Healthcare Company Details
  13.3.2 Siemens Healthcare Business Overview and Its Total Revenue
  13.3.3 Siemens Healthcare Pharmaceutical Asset Managements Introduction
  13.3.4 Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.3.5 Siemens Healthcare Recent Development
13.4 GE Healthcare
  13.4.1 GE Healthcare Company Details
  13.4.2 GE Healthcare Business Overview and Its Total Revenue
  13.4.3 GE Healthcare Pharmaceutical Asset Managements Introduction
  13.4.4 GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.4.5 GE Healthcare Recent Development
13.5 Allscripts
  13.5.1 Allscripts Company Details
  13.5.2 Allscripts Business Overview and Its Total Revenue
  13.5.3 Allscripts Pharmaceutical Asset Managements Introduction
  13.5.4 Allscripts Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.5.5 Allscripts Recent Development
13.6 Epic System
  13.6.1 Epic System Company Details
  13.6.2 Epic System Business Overview and Its Total Revenue
  13.6.3 Epic System Pharmaceutical Asset Managements Introduction
  13.6.4 Epic System Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.6.5 Epic System Recent Development
13.7 IBM Corporation
  13.7.1 IBM Corporation Company Details
  13.7.2 IBM Corporation Business Overview and Its Total Revenue
  13.7.3 IBM Corporation Pharmaceutical Asset Managements Introduction
  13.7.4 IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020)
  13.7.5 IBM Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmaceutical Asset Managements Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Asset Managements Revenue
Table 3. Ranking of Global Top Pharmaceutical Asset Managements Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutical Asset Managements Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hardware (Pharma Asset)
Table 6. Key Players of Software (Pharma Asset)
Table 7. Global Pharmaceutical Asset Managements Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pharmaceutical Asset Managements Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pharmaceutical Asset Managements Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pharmaceutical Asset Managements Market Share by Regions (2015-2020)
Table 11. Global Pharmaceutical Asset Managements Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pharmaceutical Asset Managements Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pharmaceutical Asset Managements Market Growth Strategy
Table 17. Main Points Interviewed from Key Pharmaceutical Asset Managements Players
Table 18. Global Pharmaceutical Asset Managements Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pharmaceutical Asset Managements Market Share by Players (2015-2020)
Table 20. Global Top Pharmaceutical Asset Managements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Managements as of 2019)
Table 21. Global Pharmaceutical Asset Managements by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmaceutical Asset Managements Product Solution and Service
Table 24. Date of Enter into Pharmaceutical Asset Managements Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pharmaceutical Asset Managements Market Size Share by Type (2015-2020)
Table 28. Global Pharmaceutical Asset Managements Revenue Market Share by Type (2021-2026)
Table 29. Global Pharmaceutical Asset Managements Market Size Share by Application (2015-2020)
Table 30. Global Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pharmaceutical Asset Managements Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 34. North America Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 36. North America Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 38. Europe Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 40. Europe Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 42. Europe Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 44. China Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 46. China Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 47. China Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 48. China Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 49. China Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 50. Japan Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 52. Japan Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 54. Japan Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 58. Southeast Asia Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 60. Southeast Asia Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 62. India Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 64. India Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 65. India Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 66. India Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 67. India Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pharmaceutical Asset Managements Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pharmaceutical Asset Managements Market Share (2019-2020)
Table 70. Central & South America Pharmaceutical Asset Managements Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pharmaceutical Asset Managements Market Share by Type (2015-2020)
Table 72. Central & South America Pharmaceutical Asset Managements Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pharmaceutical Asset Managements Market Share by Application (2015-2020)
Table 74. McKesson Corporation Company Details
Table 75. McKesson Corporation Business Overview
Table 76. McKesson Corporation Product
Table 77. McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 78. McKesson Corporation Recent Development
Table 79. Cerner Corporation Company Details
Table 80. Cerner Corporation Business Overview
Table 81. Cerner Corporation Product
Table 82. Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 83. Cerner Corporation Recent Development
Table 84. Siemens Healthcare Company Details
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Product
Table 87. Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 88. Siemens Healthcare Recent Development
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Product
Table 92. GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 93. GE Healthcare Recent Development
Table 94. Allscripts Company Details
Table 95. Allscripts Business Overview
Table 96. Allscripts Product
Table 97. Allscripts Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 98. Allscripts Recent Development
Table 99. Epic System Company Details
Table 100. Epic System Business Overview
Table 101. Epic System Product
Table 102. Epic System Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 103. Epic System Recent Development
Table 104. IBM Corporation Company Details
Table 105. IBM Corporation Business Overview
Table 106. IBM Corporation Product
Table 107. IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2015-2020) (Million US$)
Table 108. IBM Corporation Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmaceutical Asset Managements Market Share by Type: 2020 VS 2026
Figure 2. Hardware (Pharma Asset) Features
Figure 3. Software (Pharma Asset) Features
Figure 4. Global Pharmaceutical Asset Managements Market Share by Application: 2020 VS 2026
Figure 5. Anti-drug Counterfeiting Case Studies
Figure 6. Supply Chain Management Case Studies
Figure 7. Other Case Studies
Figure 8. Pharmaceutical Asset Managements Report Years Considered
Figure 9. Global Pharmaceutical Asset Managements Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pharmaceutical Asset Managements Market Share by Regions: 2020 VS 2026
Figure 11. Global Pharmaceutical Asset Managements Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pharmaceutical Asset Managements Market Share by Players in 2019
Figure 14. Global Top Pharmaceutical Asset Managements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Managements as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Asset Managements Revenue in 2019
Figure 16. North America Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pharmaceutical Asset Managements Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. McKesson Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. McKesson Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 25. Cerner Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Cerner Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 27. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Siemens Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 29. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GE Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 31. Allscripts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allscripts Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 33. Epic System Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Epic System Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 35. IBM Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. IBM Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed